Document Detail


Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction.
MedLine Citation:
PMID:  24535227     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The human histamine receptor H1 (HRH1) gene is located on chromosome 3p25 and encodes for a 487 amino acid G protein-coupled receptor (GPCR) with a long third intracellular loop (IL3). The HRH1 predominantly couples to Gαq/11 proteins, leading to the activation of phospholipase C (PLC) and subsequent release of the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG) followed by the activation of PKC and the release of [Ca2+]i. In the present study, we identified HRH1 genes from 14 vertebrate genomes and found that HRH1 exists in all types of vertebrates including fish, amphibians, birds and mammals. We identified 88 SNPs including 4 available alleles disrupting an existing exonic splicing enhancer and 84 SNPs causing missense mutation, which may impact the effect of histamine on the HRH1 protein. We found that the human HRH1 gene was expressed in many tissues or organs, and predominant expression of HRH1 was shown in the bone marrow, whole blood, lymph node, thymus, brain, cerebellum, retina, spinal cord, heart, smooth muscle, skeletal muscle, small intestine, colon, adipocytes, kidney, liver, lung, pancreas, thyroid salivary gland, skin, ovary, uterus, placenta, prostate and testis. When searched in the PrognoScan database, human HRH1 was also found to be expressed in bladder cancer, blood cancer, brain cancer, breast cancer, colorectal cancer, eye cancer, head and neck cancer, lung cancer, ovarian cancer, skin cancer and soft tissue cancer tissues. The relationship between the expression of HRH1 and prognosis was found to vary in different types of cancers, even in the same cancer from different databases. This implies that the function of HRH1 in these tumors may be multidimensional. GR, STAT5A and c-Myb regulatory transcription factor binding sites were identified in the HRH1 gene upstream (promoter) region, which may be involved in the effect of HRH1 in tumors.
Authors:
Minghai Wang; Xiaolong Wei; Lianghui Shi; Bin Chen; Guohai Zhao; Haiwei Yang
Related Documents :
20722497 - Time perspective in hereditary cancer: psychometric properties of a short form of the z...
16609047 - Innovations and challenges in melanoma: summary statement from the first cambridge conf...
7981847 - Recall bias in disease status associated with perceived exposure to hazardous substances.
24821107 - Dna methylation profiles in ovarian cancer: implication in diagnosis and therapy (review).
14666377 - Primary lung cancer: treatment with radio-frequency thermal ablation.
15883277 - Second primary cancers after enrollment in the coms trials for treatment of choroidal m...
Publication Detail:
Type:  Journal Article     Date:  2014-02-10
Journal Detail:
Title:  International journal of molecular medicine     Volume:  33     ISSN:  1791-244X     ISO Abbreviation:  Int. J. Mol. Med.     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-02-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9810955     Medline TA:  Int J Mol Med     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1019-26     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of the thiazole Schiff bases as [Formula: see text]-glucuronidase inhibitors and their in...
Next Document:  The gut or the brain?-gastrointestinal misdiagnoses of infantile brain tumors.